Statin therapy in the perioperative period

Reviews in Cardiovascular Medicine

Volumn 12, Issue 1, 2011, Pages 30-37

  Lander, Jeffrey S ^a   Coplan, Neil L ^a  

^a LENOX HILL HOSPITAL   (United States)

Author keywords

Perioperative medication; Prevention; Statins

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CREATINE KINASE; CREATINE KINASE MB; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ABDOMINAL AORTA ANEURYSM; ACUTE HEART INFARCTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CARDIOVASCULAR RISK; CARDIOVASCULAR SURGERY; CAROTID ENDARTERECTOMY; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CREATINE KINASE BLOOD LEVEL; DEATH; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; HUMAN; MYOPATHY; PERIOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; TREATMENT INDICATION; PRACTICE GUIDELINE; RISK ASSESSMENT; SURGERY; TREATMENT OUTCOME; VASCULAR SURGERY;

ADRENERGIC BETA-ANTAGONISTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PERIOPERATIVE PERIOD; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 79957712573     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: 10.3909/ricm0552     Document Type: Review

References (29)

1. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ. 2005;331:313-321.
2. Fleischmann KE, Beckman JA, Buller CE, et al. 2009 ACCF/AHA focused update on perioperative beta blockade: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009; 120:2123-2151.
3. Chopra V, Plaisance B, Cavusoglu E, et al. Perioperative beta-blockers for major noncardiac surgery: primum non nocere. Am J Med. 2009;122:222-229.
4. Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353:349-361. (Pubitemid 41132339)
5. Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV). Ann Surg. 2009;249:921-926.
6. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003;107:1848-1851. (Pubitemid 36444123)
7. O'Neil-Callahan K, Katsimaglis G, Tepper MR, et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol. 2005;45:336-342. (Pubitemid 40186781)
8. Lindenauer PK, Pekow P, Wang K, et al. Lipid lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA. 2004;291:2092-2099. (Pubitemid 38580152)
9. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004;39:967-975; discussion 975-976.
10. McGirt MJ, Perler BA, Brooke BS, et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg. 2005;42:829-836. (Pubitemid 41571941)
11. Kennedy J, Quan H, Buchan AM, et al. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke. 2005;36:2072-2076. (Pubitemid 41429222)
12. LaMuraglia GM, Stoner MC, Brewster DC, et al. Determinants of carotid endarterectomy anatomic durability: effects of serum lipids and lipid-lowering drugs. J Vasc Surg. 2005;41:762-768. (Pubitemid 40693795)
13. Noordzlj PG, Polermans D, Schouten O, et al. Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgery. Coron Artery Dis. 2007;18:67-72. (Pubitemid 44973759)
14. Kertai MD, Boersma E, Westerhout CM, et al. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and non-fatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg. 2004;28:343-352. (Pubitemid 39207082)
15. Kertai MD, Boersma E, Westerhout CM, et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med. 2004;116:96-103. (Pubitemid 38056662)
16. Schouten O, Hoeks SE, Welten GM, et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol. 2007;100:316-320. (Pubitemid 47041993)
17. Le Manach Y, Godet G, Coriat P, et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg. 2007;104:1326-1333. (Pubitemid 46795280)
18. Schouten O, Kertai MD, Bax JJ, et al. Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. Am J Cardiol. 2005;95:658-660. (Pubitemid 40255263)
19. Kapoor AS, Kanji H, Buckingham J, et al. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systemic review of controlled studies. BMJ. 2006;333:1149.
20. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Non-cardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 2007;50:1707-1732.
21. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106: 3143-3421.
22. Heart Protection Study Collaborative Group. The MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
23. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301-1307.
24. Sacks FM, Pfeffer MA, Moyer LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335:1001-1009. (Pubitemid 26338729)
25. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615-1622. (Pubitemid 28248586)
26. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
27. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109:III-39-III-43.
28. Ray KK, Cannon CP. The potential relevance of the multiple lipid-independent (plelotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol. 2005;46:1425-1433. (Pubitemid 41446176)
29. Cubeddu LX, Seamon MJ. Statin withdrawal: clinical implications and molecular mechanisms. Pharmacotherapy. 2006;26:1288-1296. (Pubitemid 44306889)